CancerCare Manitoba
 
 
 
 
Dr. Robert P.C. Shiu
Dr. Robert P.C. Shiu
Professor Department of Physiology
Director (DNA Laboratory), Director (Protein Polypeptide Hormone Lab)

Degrees:
B.Sc. (Hons) (Biochemistry), McGill Univ., 1969 
M.Sc. (Biochemistry), McGill Univ., 1971 
Ph.D. (Experimental Medicine), McGill Univ., 1974 

Mailing Address:
Dept. of Physiology
University of Manitoba
770 Bannatyne Ave. Rm. P304
Winnipeg, MB R3E 0W9

Tel: (204) 787-3327    
Fax: 787-2190    
Lab: 787-3325
E-mail:  rshiu@cc.umanitoba.ca

Research Interests:

This research unit is made up of two laboratories: The Protein and Polypeptide Hormone Laboratory and The DNA Laboratory. This unit conducts research in the area of molecular endocrinology / cancer biology, with emphasis on the role of reproductive hormones in health (pregnancy / lactation) and disease (breast cancer) processes. Ongoing research projects are directed towards the study of the roles and molecular mechanisms of actions of protein and steroid hormones, as well as oncogenes and growth factors, in the regulation of growth and function of normal and cancer cells. 

A multidisciplinary approach is used to conduct the above research, although molecular biology / recombinant DNA biotechnology, which encompasses such techniques as gene cloning and targeting in cell cultures and transgenic mice, is the major tool used. The research milieu is made up of a staff of experienced doctorate research associates and a support staff of skilled technologists and a secretary. The youth wing of this research unit is made up of a group of inspired post-doctoral fellows and graduate students. 

Recent Publications

  1. Shiu PC, Friesen HG. Mechanisms of action of prolactin in the control of mammary gland function. Ann Rev Physiol 42:83,1980. 
  2. Myal Y, Shiu RPC, Bhaumick B, Bala M. Receptor binding and growth promoting activity of insulin-like growth factors in human breast cancer cells (T-47D) in culture. Cancer Res 44:5486, 1984. 
  3. Dembinski T, Leung CKH, Shiu RPC. Evidence for a novel pituitary factor that potentiates the mitogenic effect of estrogen in human breast cancer cells. Cancer Res 45:3083, 1985. 
  4. Shiu RPC, Murphy LC, Tsuyuki D, Myal Y, Lee-Wing M, Iwasiow B. Biological actions of prolactin in human breast cancer. Rec Progr Horm Res 43:277, 1987. 
  5. Myal Y, Robinson D, Tsuyuki D, Iwasiow B, Wong P, Shiu RPC. The human prolactin-inducible protein (PIP)/gross cystic disease fluid protein (GCDFP-15) gene: Cloning, structure and hormonal regulation. Mol Cell Endocrinol 80:165, 1991. 
  6. Watson PH, Pon R, Shiu RPC. Inhibition of c-myc expression by phosphorothioate antisense oligodeoxynucleotides identifies a critical role for c-myc in the growth of human breast cancer. Cancer Res 51:3996, 1991. 
  7. Dubik D, Shiu RPC. An estrogen response region of the human c-myc gene: evidence for a new estrogen transactivation mechanism. Oncogene 7:1587, 1992. 

PubMed Listed Publications



Lab Members

Name Title ID # Email Address Phone #
BLANCHARD, Ann Technician L308 Med. Bldg ablanch@cc.umanitoba.ca, 789-3325
FRESNOZA, Agnes Technician      
IWASIOW, Barbara Technician P304 Path. Bldg iwasiowb@ms.umanitoba.ca, 789-3325
VERVAET, Gaby RA- Technician P304 Path. Bldg gabiskyv@hotmail.com, 787-3325
YARMILL, Alison Technician L308 Med. Bldg yarmilla@cc.umanitoba.ca, 789-3325